BGLC Financials

BioNexus Gene Lab Corp Common stock - Financial statements & key metrics

Stock Price

$1.47

Market Cap

$6.09M

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$9.51M

Gross Profit

Operating Income

Net Income

$1.60M

EPS (Diluted)

$-0.09

Cash Flow Highlights

Operating Cash Flow

$-2.23M

CapEx

Free Cash Flow

Profitability Metrics

Net Margin

16.8%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is BGLC revenue?

BGLC's most recent quarterly revenue was $9.51M. Annual revenue can be calculated by summing the four most recent quarters.

Is BGLC profitable?

BGLC reported a profit of $1.60M in the most recent quarter. The net profit margin is 16.8%.

What is BGLC market cap?

BGLC has a market capitalization of $6.09M, making it a small-cap stock.

Does BGLC have debt?

View BGLC's balance sheet for debt information.

What is BGLC cash flow?

Cash flow data is available in the full financial statements.